Ocular Therapeutix, Inc. (OCUL)

10.78 -0.20 (-1.87%) USD  |  NASDAQ  |  Mar 03, 16:00
10.75 -0.02 (-0.23%) After-Hours: 18:35
More

Ocular Therapeutix Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Abbott Laboratories Upgrade
EyePoint Plc Upgrade
Quince Therapeutics, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade